Jose-Carlos Gutiérrez-Ramos

Jose-Carlos Gutiérrez-Ramos is the founder of Centers for Therapeutic Innovation.
Currently, Dr. Gutiérrez-Ramos is Chief Executive Officer at Excaliard Pharmaceuticals, Inc., Independent Non-Executive Director at Bicycle Therapeutics Plc since 2021, and Chief Science Officer & Senior Vice President at Danaher Corp.
since 2021.
Formerly, Dr. Gutiérrez-Ramos was President & Chief Executive Officer at Synlogic Operating Co., Inc. from 2015 to 2018, President, Chief Executive Officer & Director at Synlogic, Inc. from 2015 to 2018, President, Chief Executive Officer & Director at Repertoire Immune Medicines, Inc. from 2018 to 2020, President & Chief Executive Officer at Cogen Immune Medicine, Inc., Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020, Independent Director at Oryzon Genomics SA from 2018 to 2020, Director at Evelo Biosciences, Inc. from 2019 to 2020 and from 2022 to 2023, Group Senior VP-Research & Development at Pfizer Inc. from 2010 to 2015, Vice President-Inflammation at Millennium Pharmaceuticals, Inc., Senior Vice President at Avidia, Inc. in 2007, Global Head-Global Drug Discovery at AbbVie, Inc. from 2020 to 2021, Senior Vice President & Head-Immuno Inflammation at GSK Plc, Chief Scientific Officer at Genetrix, Inc., Chief Scientific Officer at Peptimmune, Inc. from 2009 to 2011, Member at Basel Institute for Immunology, Assistant Professor at Harvard Medical School, Senior Vice President at GlaxoSmithKline AG, and Professor at National Center for Biotechnology Information.
Education includes undergraduate studies at Universidad Complutense de Madrid and a doctorate from Universidad Autónoma de Madrid.